Ananda Pharma PLC Sustainability Reports

Ananda Pharma PLC develops cannabinoid-based pharmaceutical products and research programmes for health conditions in the United Kingdom.

Sector: Manufacturing

Country: United Kingdom

Exchange: Aquis Stock Exchange

LEI: 894500DFM8VOC5FW4X47

7 reports from 2019 to 2025

• Ananda Pharma PLC 2025 Annual Report and Financial Statements
• Ananda Pharma PLC 2024 Annual Report and Financial Statements
• Ananda Pharma PLC 2023 Consolidated Audited Financial Statements
• Ananda Pharma PLC 2022 Audited Financial Statements
• Ananda Pharma PLC 2021 Audited Financial Statements